FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non ‐muscle‐invasive bladder cancer (NMIBC)

BJU International,Volume 0, Issue ja, -Not available-.

Source: BJU International - August 18, 2018 Category: Urology & Nephrology Authors: Johannes Breyer , Ralph M. Wirtz , Philipp Erben , Sebastien Rinaldetti , Thomas S. Worst , Robert Stoehr , Markus Eckstein , Danijel Sikic , Stefan Denzinger , Maximilian Burger , Arndt Hartmann , Wolfgang Otto Source Type: research